eli lilly gip/glp-1 GLP4 coming out will release animal study data for at QUINTUPLE AGONIST at #ADA2026 For reference: Semaglutide= GLP1 Tirzepatide = GLP1/GIP Retatrutide = GLP1/GIP/Glucagon New Mol = GLP1/GIP/Glucagon/Amylin/Calcitonin Early rat GLP-1 use tripled among non-diabetics,

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinsons disease occurring with type 2 diabetes in a Taiwanese population cohort

This new study underscores one important reality: patients are highly motivated to lose weight and may tolerate side effects if they believe the drug is working

Another consequence of this shift is the changing role of clinical expertise

If your travel duration is less than four weeks, you may not need to worry about constant refrigeration once you have started using a pen

doi: 10.1371/journal.pone.0004962 77 DuarteAISjgrenMSantosMSOliveiraCRMoreiraPIBjrkqvistM

Another study worth considering is the 2020 study that found over 140 adverse vision effects from the use of semaglutide, the active ingredient in Ozempic